Concordia International Corp. said Jordan Kupinsky was stepping down as the company's nonexecutive chairman.
The Canadian pharmaceutical company, which is looking to cut its debt by US$2.4 billion, also appointed Randy Benson to its board.
"We believe that his experience in corporate recapitalizations will benefit our stakeholders as we move forward with our capital structure realignment," Concordia's interim CEO, Graeme Duncan, said of the appointee.
